1. Home
  2. FSUN vs CGEM Comparison

FSUN vs CGEM Comparison

Compare FSUN & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSUN

FirstSun Capital Bancorp

HOLD

Current Price

$38.21

Market Cap

966.0M

Sector

Finance

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.24

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSUN
CGEM
Founded
1892
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.0M
671.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FSUN
CGEM
Price
$38.21
$10.24
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$45.67
$28.00
AVG Volume (30 Days)
148.6K
1.4M
Earning Date
01-26-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
3.52
N/A
EPS
3.16
N/A
Revenue
$384,497,000.00
N/A
Revenue This Year
$18.64
N/A
Revenue Next Year
$49.01
N/A
P/E Ratio
$11.96
N/A
Revenue Growth
10.48
N/A
52 Week Low
$29.95
$5.68
52 Week High
$45.32
$13.33

Technical Indicators

Market Signals
Indicator
FSUN
CGEM
Relative Strength Index (RSI) 68.11 48.74
Support Level $37.13 $10.01
Resistance Level $36.15 $13.10
Average True Range (ATR) 1.00 0.99
MACD 0.59 -0.16
Stochastic Oscillator 91.67 6.80

Price Performance

Historical Comparison
FSUN
CGEM

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: